Drugs / MDMA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT07704762 Comparator | Oct 2026 → Jan 2028 expected | post-traumatic stress disorder | U.S. Army Medical Research and Development Command | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDMA | “Participants in this arm will receive lower dose of MDMA integrated with Acceptance and Commitment Therapy (ACT)” NCT07704762 ↗ |